Semin Plast Surg 2007; 21(3): 159-166
DOI: 10.1055/s-2007-991184
© Thieme Medical Publishers

Laser Treatment of Pediatric Vascular Lesions

Patrick D. Cole1 , Michael L. Sonabend2 , Moise L. Levy3
  • 1Division of Plastic Surgery, Baylor College of Medicine, Houston, Texas
  • 2Department of Dermatology, Baylor College of Medicine, Houston, Texas
  • 3Dermatology Services and Birthmark Center, Texas Children's Hospital, Houston, Texas
Further Information

Publication History

Publication Date:
20 November 2007 (online)

ABSTRACT

Since its introduction in 1967, laser therapy has benefited patients and physicians alike. After the first clinical application by Goldman (Anderson RR, Parrish JA. Science 1983;220:524-527), laser therapy has become indispensable in the management of vascular birthmarks. In selecting a proper balance of wavelength, pulse duration, and energy density (fluence), the physician can mold laser energy to effectively manage lesions once considered untreatable. Now, the vast array of lesions amenable to laser therapy continues to expand. By advancing our understanding of both laser technology and vascular lesion biology, the goal of providing optimal clearance with minimal morbidity moves ever closer.

REFERENCES

  • 1 Anderson R R, Parrish J A. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation.  Science. 1983;  220 524-527
  • 2 Arndt K A. Argon laser therapy of small cutaneous vascular lesions.  Arch Dermatol. 1982;  118 220-224
  • 3 Dixon J A, Huether S, Rotering R H. Hypertrophic scarring in argon laser treatment of portwine stains.  Plast Reconstr Surg. 1984;  73 771-780
  • 4 Chang C J, Nelson J S. Cryogen spray cooling and higher fluence pulsed dye laser treatment improve port-wine stain clearance while minimizing epidermal damage.  Dermatol Surg. 1999;  25 767-772
  • 5 Apfelberg D B, Maser M R, Lash H, Rivers J. The argon laser for cutaneous lesions.  JAMA. 1981;  245 2073-2075
  • 6 Geronemus R G. Argon laser for the treatment of cutaneous lesions.  Clin Dermatol. 1995;  13 55-58
  • 7 No D, Dierick C, McClaren M et al.. Pulsed alexandrite treatment of bulky vascular malformations.  Lasers Surg Med. 2003;  15 26
  • 8 Apfelberg D B. Argon-pumped tunable dye laser.  Ann Plast Surg. 1994;  32 394-400
  • 9 Rohrer T E, Chatrath V, Iyengar V. Does pulse stacking improve results with variable-pulse pulsed dye lasers?.  Dermatol Surg. 2004;  30 163-167
  • 10 Anderson R R, Ross E V. Laser-tissue interactions. In: Fitzpatrick MP, Goldman MP Cosmetic Laser Surgery. St. Louis, MO; Mosby 2000: 109-115
  • 11 Levine V J, Geronemus R G. Adverse effects associated with the 577- and 585-nanometer pulsed dye laser in the treatment of cutaneous vascular lesions: a study of 500 patients.  J Am Acad Dermatol. 1995;  32 613-617
  • 12 Garden J M, Polla L L, Tan O T. The treatment of port-wine stains by the pulsed dye laser. Analysis of pulse duration and long-term therapy.  Arch Dermatol. 1998;  124 889-896
  • 13 Tan O T, Sherwood K, Gilchrest B A. Treatment of children with portwine stains using the flashlamp-pumped pulsed dye laser.  N Engl J Med. 1989;  320 416-421
  • 14 Fitzpatrick R E, Lowe N J, Goldman M P et al.. Flashlamp-pumped pulsed dye laser treatment of port-wine stains.  J Dermatol Surg Oncol. 1994;  20 743-748
  • 15 Sommer S, Sheehan-Dave R A. Pulsed dye laser treatment of port-wine stains in pigmented skin.  J Am Acad Dermatol. 2000;  42 667-671
  • 16 Waldorf H A, Alster T S, McMillan K et al.. Effect of dynamic cooling on 585-nm pulsed dye laser treatment of port-wine stain birthmarks.  Dermatol Surg. 1997;  23 657-662
  • 17 Renfro L, Geronemus R G. Anatomical differences of port-wine stains in response to treatment with the pulsed dye laser.  Arch Dermatol. 1993;  129 182-188
  • 18 Lou W W, Geronemus R G. Treatment of port-wine stains by variable pulsed width pulsed dye laser with cryogen spray: a preliminary study.  Dermatol Surg. 2001;  27 963-965
  • 19 Dierickx C C, Casparian J M, Vengopalan V, Farinelli W A, Anderson R R. Thermal relaxation of port-wine stain vessels probed in vivo: the need for 1-10 millisecond laser pulse treatment.  J Invest Dermatol. 1995;  105 709-714
  • 20 Uebelhoer N S, Bogle M A, Dover J S, Rohrer T E, Arndt K A. Comparison of KTP (532nm Gemini) with pulsed dye laser (595nm, V-Beam) in the treatment of facial telangiectasia and redness. Unpublished data
  • 21 Butler E G, McClellan S D, Ross E V. Split face treatment of photodamaged skin with a 10 mm spot KTP laser vs IPL: a cheek-to-cheek comparison.  Lasers Surg Med. 2006;  38 124-128
  • 22 Yang M U, Yaroslavsky A N, Farinelli W A et al.. Long pulsed Nd:YAG treatment for port wine stains.  Am Acad Dermatol. 2005;  52 480-490
  • 23 Parlette E C, Groff W F, Kinshella M J, Domankevitz Y, Ross E V. Optimal pulse durations for the treatment of leg telangiectasias with a neodymium YAG laser.  Lasers Surg Med. 2006;  17 342-347
  • 24 Iyer S, Fitzpatrick R E. Long-pulsed dye laser treatment for facial telangiectasias and erythema: evaluation of a single purpuric pass versus multiple subpurpuric passes.  Dermatol Surg. 2005;  31 898-902
  • 25 Lupton J R, Alster T S, Romero P. Clinical comparison of sclerotherapy versus long-pulsed Nd:YAG laser treatment for lower extremity telangiectases.  Dermatol Surg. 2002;  28 694-697
  • 26 Goldberg D J, Meine J G. A comparison of four frequency-doubled Nd:YAG (532 nm) laser systems for treatment of facial telangiectasias.  Dermatol Surg. 1999;  25 463-467
  • 27 Negishi K, Kushikata N, Tezuka Y et al.. Study of the incidence and nature of very subtle epidermal melasmaQ in relation to intense pulsed light treatment.  Dermatol Surg. 2004;  30 881-886
  • 28 Negishi K, Tezuka Y, Kushikata N, Wakamatsu S. Photorejuvenation for Asian skin by intense pulsed light.  Dermatol Surg. 2001;  27 627-632
  • 29 Dover J S, Bhatia A C, Stewart B, Arndt K A. Adjunctive use of topical aminolevulinic acid with intense pulsed light in the treatment of photoaging.  Arch Dermatol. 2005;  141 1247-1252
  • 30 Burton B K, Schulz C J, Angle B, Burd L I. An increased incidence of hemangiomas in infants born following chorionic villus sampling (CVS).  Prenat Diagn. 1995;  15 209-214
  • 31 David L R, Malek M M, Argenta L C. Efficacy of pulse dye laser therapy for the treatment of ulcerated hemangiomas: a review of 78 patients.  Br J Plast Surg. 2003;  56 317-327
  • 32 Sadick N S. A dual wavelength approach for laser/intense pulsed light source treatment of lower extremity veins.  J Am Acad Dermatol. 2002;  46 66-72
  • 33 Kaudewitz P, Klovekorn W, Rother W. Effective treatment of leg vein telangiectasia with a new 940 nm diode laser.  Dermatol Surg. 2001;  27 101-106
  • 34 Dover J S, Sadick N S, Goldman M P. The role of lasers and light sources in the treatment of leg veins.  Dermatol Surg. 1999;  25 328-336
  • 35 Kauvar A NB. The role of lasers in the treatment of leg veins.  Semin Cutan Med Surg. 2000;  19 245-252
  • 36 Sadick N S. Long-term results with a multiple synchronized-pulse 1064 nm Nd:YAG laser for the treatment of leg venulectasias and reticular veins.  Dermatol Surg. 2001;  27 365-369
  • 37 Goldman M P. Laser and sclerotherapy treatment of leg veins: my perspective on treatment outcomes.  Dermatol Surg. 2002;  28 969-970
  • 38 Massey R A, Katz B E. Successful treatment of spider leg veins with a high-energy, long-pulse, frequency-doubled neodymium:YAG laser (HELP-G).  Dermatol Surg. 1999;  25 677-680
  • 39 Passeron T, Olivier V, Duteil L et al.. The new 940-nanometer diode laser: an effective treatment for leg venulectasia.  J Am Acad Dermatol. 2003;  48 768-774
  • 40 Bernstein E F. Clinical characteristics of 500 consecutive patients presenting for laser removal of lower extremity spider veins.  Dermatol Surg. 2001;  27 31-33
  • 41 Lai C H, Hanson S G, Mallory S B. Lymphangioma circumscriptum treated with pulsed dye laser.  Pediatr Dermatol. 2001;  18 509-510
  • 42 Weingold D H, White P F, Burton C S. Treatment of lymphangioma circumscriptum with tunable dye laser.  Cutis. 1990;  45 365-366
  • 43 Bekhor P. Lasers in Dermatology.  Aust Fam Physician. 1992;  21 577-580
  • 44 Telenkov S A, Dave D P, Sethuraman S, Akkin T, Milner T E. Differential phase optical coherence probe for depth-resolved detection of photothermal response in tissue.  Phys Med Biol. 2004;  49 111-119
  • 45 Choi B, Majaron B, Nelson J S. Computational model to evaluate port wine stain depth profiling using pulsed photothermal radiometry.  J Biomed Opt. 2004;  9 299-307
  • 46 Sivarajan V, Mackay I R. Noninvasive in vivo assessment of vessel characteristics in capillary vascular malformations exposed to five pulsed dye laser treatments.  Plast Reconstr Surg. 2005;  115 1245-1252
  • 47 Zhang R, Verkruysse W, Choi B et al.. Determination of human skin optical properties from spectrophotometric measurements based on optimization by genetic algorithms.  J Biomed Opt. 2005;  10 024030
  • 48 Eubanks L E, McBurney E I. Videomicroscopy of port-wine stains: correlation of location and depth of lesion.  J Am Acad Dermatol. 2001;  44 948-951
  • 49 Cuccia D J, Bevilacqua F, Durkin A J, Tromberg B J. Modulated imaging: quantitative analysis and tomography of turbid media in the spatial-frequency domain.  Opt Lett. 2005;  30 1354-1356
  • 50 Jung B, Choi B, Durkin A J, Kelly K M, Nelson J S. Characterization of port wine stain skin erythema and melanin content using cross-polarized diffuse reflectance imaging.  Lasers Surg Med. 2004;  34 174-181
  • 51 Choi B, Ramirez-San-Juan J C, Lotfi J, Stuart Nelson J. Linear response range characterization and in vivo application of laser speckle imaging of blood flow dynamics.  J Biomed Opt. 2006;  11 041129

Patrick D ColeM.D. 

Division of Plastic Surgery, Baylor College of Medicine

1709 Dryden, Suite 1600, BCM Mail Stop: 340, Houston, TX 77030

    >